About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 40136 record(s)
Req # A-2020-001362
A report of all Health Canada ATIP requests that have been received that have the subject covid19 or coronavirus vaccine(s). The following dates on the report: Full text summary, Date request received, Number of days taken to process the request,…Organization: Health Canada
March 2021
Req # A-2020-001742
Records on Masking Mandates with respect to Covid19 for Ontario schools.Organization: Health Canada
March 2021
Req # A-2019-000533
Adverse Reaction Reports (AERs). Report numbers: E2B_01519512, E2B_01569995, E2B_01593894, E2B_01716258, E2B_01737282, E2B_01935489, E2B_01935627, E2B_01976714, E2B_02017580, E2B_02017594, E2B_02017595, E2B_02017682, E2B_02061676, E2B_02067602,…Organization: Health Canada
March 2021
Req # A-2019-000640
Adverse Reaction Reports (AERs). Report numbers: 000561687, 000721195, E2B_00526152, 000581910, 000612637.Organization: Health Canada
March 2021
Req # A-2019-000897
Adverse Reaction Reports (AERs). Report numbers: E2B_01572197, E2B_01572202, E2B_01600857, E2B_01631143, E2B_01494364, E2B_01438975, E2B_01708235, E2B_01628861, E2B_00518262, 000712824, 000713846.Organization: Health Canada
March 2021
Req # A-2019-000919
Adverse Reaction Reports (AERs). Report numbers: E2B_02500807, 000725397, E2B_02501981, E2B_02515296, E2B_02515324.Organization: Health Canada
March 2021
Req # A-2019-000990
Adverse Reaction Reports (AERs). Report numbers: E2B_02548160, E2B_02560341, E2B_02563630, E2B_02563720, E2B_02548160; E2B_02560341; E2B_02563630; E2B_02563720.Organization: Health Canada
March 2021
Req # A-2019-001001
Adverse Reaction Reports (AERs). Report numbers: 000693191, E2B_02208753, E2B_02501456, E2B_01965732, E2B_02320915 E2B_01977005, E2B_02320916, E2B_01818817, E2B_01821736, 000693898, E2B_01893037, E2B_01893099, E2B_02107256, E2B_01893790.Organization: Health Canada
March 2021
Req # A-2019-001319
Adverse Reaction Reports (AERs) for Mezavant and Mesalazine. Report numbers: E2B_02173182, E2B_02173617, E2B_02174032, E2B_02179943, E2B_02153848.Organization: Health Canada
March 2021
Req # A-2019-001359
Adverse Drug Reaction (ADR). Report number: E2B_02373859.Organization: Health Canada
March 2021